|
AU2019267105A1
|
|
Novel sulfonamide derivatives having selective Nox inhibiting activity
|
|
WO2016133446A1
|
|
N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine
|
|
CN107405318A
|
|
For treating the compound of the patient's condition related to nadph oxidase
|
|
CN104918616A
|
|
Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucleotide phosphate oxidase
|
|
CA2867412A1
|
|
Thiophene- based compounds exhibiting nox4 inhibitory activity and use thereof in therapy
|
|
WO2008008033A1
|
|
The use of naphtoquinones in the treatment and control of diabetes, insulin resistance and hyperglycemia
|
